Product Description: Ditercalinium chloride is an anticancer agent. Ditercalinium chloride inhibits human DNA polymerase gamma activity. Ditercalinium chloride can deplete mitochondrial DNA in both mouse and human cells. Ditercalinium chloride is a potential ligand against the COMMD10-AP3S1 fusion protein[1][2].
Applications: Cancer-programmed cell death
Formula: C46H50Cl2N6O2
References: [1]Okamaoto M, et al. Ditercalinium chloride, a pro-anticancer drug, intimately associates with mammalian mitochondrial DNA and inhibits its replication. Curr Genet. 2003 Aug;43(5):364-70. /[2]Sandhya Rai, et al. Ditercalinium chloride: A potential inhibitor targeting recurrent in frame COMMD10-AP3S1 fusions in CRCs. Gene Reports. 2023, 30:101739.
CAS Number: 74517-42-3
Molecular Weight: 789.83
Compound Purity: 93.37
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: DNA/RNA Synthesis